Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
US6156515A · kind A · utility
0Cited by
13References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 9, 1999 |
| Grant date | Dec 5, 2000 |
| Priority date | — |
| Expiry date | Feb 9, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/866
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are nucleic acid and amino acid sequences encoded by a novel, prostate specific gene (UC41) and diagnostic techniques for the detection of human prostate cancer utilizing such nucleic acid and amino acid sequences. Genetic probes and methods useful in monitoring the progression and diagnosis of prostate cancer are described. Methods of treatment for prostate cancer utilizing antisense constructs or antibodies specific for UC41 gene products are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.